Switching From Tirzepatide to Retatrutide: Dosing and Transition Guide
How to safely switch from tirzepatide (Mounjaro) to retatrutide. Starting doses, what to expect, the glucagon difference, and week-by-week protocols based on your current Tirz dose.
PeptIQ Team
Peptide Research & Education
PeptIQ app
Track your switch safely in PeptIQ
Log the old protocol, the new one, and how you feel — so the transition isn’t guesswork.
Under 25? Talk to a licensed clinician and get baseline labs before starting anything. Why we say this · Labs checklist
# Switching from Tirzepatide to Retatrutide: The Complete Transition Guide
If you've been on tirzepatide and want to try retatrutide, you're not starting from zero. Your GLP-1 and GIP receptors are already adapted, which changes how you should approach the switch.
This guide covers the practical details: what starting dose makes sense based on your current tirzepatide level, what the glucagon component adds (and why it matters), and what to expect during the first few weeks.
Glucagon receptor (thermogenesis, direct fat oxidation)
That third receptor is the key difference. Glucagon directly increases energy expenditure and fat breakdown—it's why retatrutide shows superior weight loss in head-to-head data.
But the glucagon component also means retatrutide can feel different even if you're adapted to tirzepatide's GLP-1/GIP effects.
Starting Dose: Where to Begin
The standard retatrutide starting dose for GLP-1-naive users is 0.25mg weekly. But you're not naive—your receptors are primed.
Starting Dose Based on Current Tirzepatide Dose
Current Tirz Dose
Recommended Reta Starting Dose
Notes
2.5mg weekly
0.5–1mg weekly
Conservative start
5mg weekly
1–1.5mg weekly
Most common scenario
7.5mg weekly
1.5–2mg weekly
Monitor for glucagon sides
10–15mg weekly
2–3mg weekly
Experienced; watch titration
General rule: Start at roughly 20–30% of your tirzepatide dose in retatrutide equivalent, then titrate based on response.
Why Not Jump Higher?
Even if your GLP-1/GIP receptors are fully adapted, the glucagon receptor is new to your system. Starting too aggressive can cause:
Different GI effects than you're used to
Unexpected energy fluctuations
Appetite changes that don't match your tirzepatide experience
Give yourself one week at your starting dose to see how the glucagon piece hits you specifically.
Week-by-Week Protocol
Week 1: First Reta Dose
Inject your starting dose (see table above)
Note: food noise may temporarily return
This is normal—the GIP ratio is different in retatrutide
Week 2: Assessment
If no new side effects:
Bump by 0.5mg (if starting dose was under 2mg)
Bump by 1mg (if starting dose was 2mg+)
If experiencing glucagon-related effects (jitteriness, different hunger pattern, mild nausea):
Stay at current dose another week
Weeks 3–6: Find Your Effective Dose
Continue titrating every 1–2 weeks
Target: find the dose where satiety + energy feel stable
Most people land between 3–6mg weekly for maintenance
Week 6+: Maintenance
Lock in your effective dose
Adjust only if plateau lasts 3+ weeks
What to Expect During Transition
The First Two Weeks
Food noise may return temporarily. Retatrutide's GIP agonism is stronger relative to GLP-1 than tirzepatide's ratio. Your brain needs time to recalibrate to the new balance.
Don't panic if week 1–2 feels "weaker" than your tirzepatide experience. The full triple-agonist effect typically stabilizes by week 3.
Glucagon effects kick in slowly. The thermogenic and fat-oxidation benefits from glucagon receptor activation take 2–3 weeks to become noticeable. This is when people often report:
If you had significant GI issues on tirzepatide, retatrutide is often better tolerated once you're past the first week.
Common Transition Mistakes
Mistake 1: Starting Too High
Just because you tolerated 10mg tirzepatide doesn't mean you should start at 5mg retatrutide. The glucagon component is genuinely new stimulation.
Fix: Start conservative, titrate fast. You can always go up quickly if everything feels smooth.
Mistake 2: Expecting Immediate Results
The glucagon receptor activation that makes retatrutide superior takes time to manifest. Weeks 1–2 are calibration, not peak performance.
Fix: Judge retatrutide at week 4–6, not week 1.
Mistake 3: Not Adjusting Protein Intake
Retatrutide's glucagon component can increase protein turnover. If you're not eating enough protein, you may lose lean mass faster than on tirzepatide.
Fix: Target 0.8–1g protein per pound of lean body mass daily. If you're unsure, err toward 150–180g daily.
Mistake 4: Comparing Week 1 Reta to Peak Tirz
You're comparing a drug you were optimized on to a drug you just started. That's not a fair comparison.
Fix: Compare Reta at 6 weeks to Tirz at 6 weeks of use.
When Retatrutide Might Not Be the Right Switch
Consider staying on tirzepatide if:
You have anxiety disorders. Glucagon receptor activation can increase sympathetic tone, which some people experience as heightened anxiety.
You're already at goal weight. Retatrutide's stronger fat-loss effect may be overkill for maintenance.
Cost is a concern. Retatrutide is currently more expensive than compounded tirzepatide in most markets.
Reconstitution and storage (illustrative example only)
> Example only, not your vial. The figures below are worked examples for a labeled vial size and diluent volume. A different mass or water volume changes every unit count. Check your label and run the reconstitution calculator.
Research-vial reconstitution uses the same concentration arithmetic people apply to other lyophilized GLP-1 listings. One worked example for a labeled 20 mg vial:
Add bacteriostatic water (BAC) to the lyophilized vial
Example mix: 2 mL BAC per 20 mg vial → 10 mg/mL
At that example concentration, 1 mg = 10 units on a U-100 syringe
Community storage language is usually refrigerated after reconstitution, with a conservative beyond-use window measured in weeks
Those unit counts only hold for that labeled mass and diluent volume. They are not a universal mix, a branded pen IFU, or a dosing protocol.
Yes. Finish your tirzepatide injection as normal, then start retatrutide on your next scheduled injection day. No washout period needed—the mechanisms overlap significantly.
Should I start Reta on the same day I would have done Tirz?
Yes. Keep your injection schedule consistent. If you were doing tirzepatide on Saturdays, do retatrutide on Saturdays.
Will my tolerance to GLP-1s transfer?
Partially. Your GLP-1 and GIP tolerance transfers, meaning you likely won't experience the severe nausea that naive users report. But the glucagon receptor is new, so some mild adjustment effects are normal.
Is retatrutide better than tirzepatide for fat loss?
In clinical trials, retatrutide shows superior weight loss (up to 24% body weight at 48 weeks vs ~21% for tirzepatide). The glucagon receptor activation adds direct thermogenesis that tirzepatide lacks.
Can retatrutide be compounded or sourced from vendors?
No. Retatrutide is investigational and not FDA-approved. FDA has stated it cannot be lawfully compounded under 503A/503B. PeptIQ does not sell peptides and does not recommend vendors. Discuss any peptide questions with a licensed healthcare provider. This is educational only — not medical advice and not a prescription.
---
Switching from tirzepatide to retatrutide is straightforward if you respect the glucagon difference. Start conservative, give it time, and you'll likely find the triple-agonist profile delivers what you were hoping for when you first started GLP-1 therapy.
Related guides & tools
Educational links only — compare mechanisms, calculators, and compound profiles. Not dosing instructions.
Is there an official tirzepatide to retatrutide conversion?
No. Retatrutide is investigational and has no FDA label, and no published trial defines a mg-for-mg switch from tirzepatide. Retatrutide trials started people low and escalated. Any switch should be planned with a licensed clinician who knows your current dose and side effects.
What is different about retatrutide versus tirzepatide?
Tirzepatide activates GIP and GLP-1 receptors. Retatrutide also activates the glucagon receptor, which is why it is called a triple agonist and why heart rate, appetite, and GI effects are worth tracking closely after a switch.
Is this GLP-1 switching guide medical advice?
No. PeptIQ publishes educational summaries and tracking tools. Talk with a licensed clinician about whether any therapy is appropriate for you.
Can I log what I read here in the PeptIQ app?
Yes. Use PeptIQ on iOS, Android, or the web to save notes, vials, and check-ins. Availability follows your App Store or Google Play region (including the US, Canada, and Australia).
Where should I go for GLP-1 telehealth questions?
If you are comparing licensed tirzepatide or semaglutide paths, see our GLP-1 telehealth partner disclosure on eligible pages. PeptIQ may earn a referral fee; offers use code PEPTIQ100 where noted.
